Arentz Law Group Reports Xarelto Verdict, Firm Offers Free Consultations for Victims
By: Arentz Law Group
This case was the first of roughly 1,400 Xarelto-related cases currently pending in the Philadelphia Court. Also pending are more than 18,500 Xarelto federal court cases which have been consolidated in an MDL at the U.S. District Court for the Eastern District of Louisiana. Plaintiffs allege that drug manufacturers Janssen Pharmaceuticals and Bayer failed to adequately warn patients of the drug's internal bleeding risks. The Xarelto lawsuits mirror those of another Philadelphia MDL, also against Janssen, claiming the drug maker aggressively marketed the psychiatric drug Risperdal while failing to warn of it's potential to cause female breast tissue growth in young men and boys.
"Though this and other verdicts awarded in pharmaceutical litigations may seem sensational to those who hear about them in the news, they are actually relatively small and all too rare with respect to the profits made by drug companies. This verdict is a great victory for victims who have been harmed by Xarelto, we hope this judgement paves the way for future compensation for all who suffered from the dangerous side effects now associated with xarelto." said Robert Arentz, managing partner and founder of Arentz Law Group.
Xarelto is Bayer's top-selling product, the company reported over $3 billion in Xarelto sales in 2016. Janssen's sales of the anticoagulant generated $2.29 billion in 2016.
Arentz Law Group is a national law firm experienced in pharmaceutical litigation. The firm is offering free, no obligation, legal consultations to patients and family members of those who have experienced serious bleeding side effects or died as a result of Xarelto. Time to file Xarelto claims is limited. Those who have experienced Xarelto bleeding side effects should speak to an attorney as soon as possible. Arentz Law Group can be reached by phone at 1-800-305-6000 or online at arentzlaw.com.
Page Updated Last on: Dec 12, 2017